EndoTODAY Old | EndoATLAS | OPD

½Äµµ | À§¿°°ú À§±Ë¾ç | À§¾Ï | ESD

| ±â»ýÃæ | ¼¼¹Ì³ª | ÇÚÁî¿Â

Home | Recent | Blog | Links

EndoTODAY ³»½Ã°æ ±³½Ç


[Fexuprazan. Fexuclue. Æ彺Ŭ·ç] - ðû

2022-7-13. ´ÚÅͺô web-seminar (log-in é©)


1. Characteristics of fexuprazan

2022-10-7 ´ÚÅͺô ½ÉÆ÷Áö¾ö screenshot - Half half dose¸¦ ÇÏ·ç µÎ¹ø ¾²´Â ¼ÀÀ̹ǷΠ°á±¹ ÇÏ·ç¿¡ half dose¸¦ ¾²´Â °Í°ú °°Àº È¿°úÀÔ´Ï´Ù. ±âÁ¸ÀÇ half half PPI´Â ÇÏ·ç ÇѹøÀε¥ ±×¿¡ ºñÇÏ¿© ´õ¿í °­·ÂÇÑ ¾àÈ¿¸¦ º¸ÀÏ °ÍÀ¸·Î »ý°¢µË´Ï´Ù.


[Symposiums]

[2022-5-28. ºÎ»ê ½ÉÆ÷Áö¾ö]

[2022-7-13. ´ÚÅͺô talk show]

log-in é©

[2023-7. ´ÚÅͺô Fexuprazan ¹ß¸Å 1Áֳ⠱â³ä talkshow]

log-in é©


[FAQ]

[2022-7-13. Web-seminar »çÀü Áú¹®]

Q1. Æå¼öŬ·ç ¹Ý°¨±â°¡ ±æ¾î¼­ °úµµÇÑ À§»êºÐºñ ¾ïÁ¦·Î ÀÎÇÑ ºÎÀÛ¿ëÀ» ¿ì·ÁÇϽô ºÐµéÀÌ ÀÖÀ¸½Åµ¥, ±³¼ö´ÔÀÇ Æå¼öŬ·ç ÀÓ»ó °æÇè¿¡¼­ °ü·ÃÇÑ ºÎÀÛ¿ëÀº ¾øÀ¸¼Ì´ÂÁö¿ä?

EndoTODAY »ý°¢. ¹Ý°¨±â°¡ ±æ¾î¼­ 24½Ã°£ Áö¼ÓÀûÀÎ È¿°ú¸¦ ³»´Âµ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù. ±×·¯³ª Àüü À§»êºÐºñ·® °¨¼Ò¿¡ ¹ÌÄ¡´Â ¿µÇâÀº »ý°¢º¸´Ù Å©Áö ¾Ê½À´Ï´Ù. ¾Æ·¡ ±×¸² ÂüÁ¶

Q2. Åõ¿© 1ÀÏÂ÷ ºü¸¥ ¾àÈ¿ ¹ßÇöÀÌ ÀÓ»ó°¡ ¼±»ý´Ôµé¿¡°Ô ¾ó¸¶³ª Áß¿äÇÑÁö ±³¼ö´ÔÀÇ °ßÇظ¦ ºÎŹµå¸³´Ï´Ù

EndoTODAY »ý°¢. ¸ÔÀÚ¸¶ÀÚ ÁÁ¾ÆÁö´Â °Í(PCAB)°ú 3ÀÏ ÈÄ ÁÁ¾ÆÁö´Â °Í(PPI)ÀÇ Â÷ÀÌ.

Q3. Æå¼öŬ·çÀÇ 3»óÀÓ»ó Áß È¯ÀÚÁõ»ó ¼³¹®(RDQ)À» ÅëÇØ °³¼±µÇ´Â Á¤µµ¸¦ »ìÆ캻 °ÍÀº 1Â÷ ÀÇ·á±â°üÀÇ Çö½Ç¿¡ ´õ ÀûÇÕÇÑ Á¢±ÙÀ̶ó°í ±³À° ¹Þ¾Ò½À´Ï´Ù. ÀÌ·± ȯÀÚ Áõ»óÆò°¡ °á°úÀÇ Á߿伺ÀÌ ¾î´À Á¤µµÀÎÁö ±³¼ö´Ô²²µµ µé¾îº¸°í ½Í½À´Ï´Ù.

EndoTODAY »ý°¢. ÀÇ»ç´Â ȯÀÚ¸¦ ºÁ¾ß ÇÕ´Ï´Ù. ¹°·Ð Ã¥µµ °¡²û ºÁ¾ß ÇÏ°í ¼¼¹Ì³ªµµ °¡²û Âü¼®ÇØ¾ß ÇÕ´Ï´Ù. ±×·¯³ª ȯÀÚ¸¦ Àß º¸½Ã¸é ´äÀÌ ³ª¿É´Ï´Ù.

Q4. À§½Äµµ ¿ª·ùÁúȯ ȯÀںеéÀÇ ¾ß°£ Áõ»óÀÌ ºó¹øÇÑÁö ±Ã±ÝÇÕ´Ï´Ù, ÇØ´ç Áõ»óÀÇ È¯Àںе鿡°Ô Æå¼öŬ·ç°¡ È¿°úÀûÀÎ ´ë¾ÈÀÌ µÉ ¼ö ÀÖ´ÂÁö ±Ã±ÝÇÕ´Ï´Ù

EndoTODAY »ý°¢. °¡²û ÀÖ´Â °Í °°½À´Ï´Ù. ´Ù¼Ò overestimationµÇ´Â °æ¿ì°¡ ÀÖ±â´Â ÇÏÁö¸¸ ºÐ¸íÈ÷ ÀϺΠȯÀÚµéÀº ¾ß°£Áõ»óÀ¸·Î °í»ýÇÕ´Ï´Ù.

Q5. PPI¸¦ À¯Áö¿ä¹ýÀ¸·Î½á Àå±âº¹¿ëÇϽô ȯÀÚ ºÐµéÀº ¾î¶² ÄÉÀ̽º À¯ÇüÀÎÁö ±Ã±ÝÇÕ´Ï´Ù. ±×·¯ÇÑ ÄÉÀ̽º ȯÀںеéÀÌ ¾ó¸¶³ª ¸¹ÀºÁöµµ ±Ã±ÝÇÕ´Ï´Ù.

EndoTODAY »ý°¢. ¾öû ¸¹½À´Ï´Ù. ¾à°£ÀÇ hiatal hernia°¡ ÀÖ´Â GERD ȯÀÚ°¡ ¿ÏÀüÈ÷ ¾àÀ» ²÷±â´Â ¾î·Æ½À´Ï´Ù. Threshold therapy (PPI³ª P-CABÀ̳ª ¸ðµÎ ÁÁ½À´Ï´Ù)³ª on-demand therapy (´ç¿¬È÷ P-CABÀÔ´Ï´Ù) µîÀÌ ÇÊ¿äÇÑ È¯ÀÚµéÀÔ´Ï´Ù.

Q6. PPI³ª P-CABÀ¸·Î ÀÎÇØ »êºÐºñ°¡ ¾ïÁ¦µÇ¸é ¼ÒÈ­ºÒ·®ÀÌ ¿À±â ¶§¹®¿¡ PKT ¾à¹° º´¿ëÀ» ±Ç°íÇÑ´Ù°í µé¾ú½À´Ï´Ù. ¾î´À Á¤µµ ¼öÁØÀ¸·Î ±Ç°íµÇ´Â °ÍÀÎÁö ±Ã±ÝÇÕ´Ï´Ù.

EndoTODAY »ý°¢. ±Ç°í °­µµ´Â ¸Å¿ì ¾àÇÕ´Ï´Ù. Àú´Â °ÅÀÇ »ç¿ëÇÏÁö ¾Ê½À´Ï´Ù.


[References]

1. Fexuprazan ȸ»ç Á¦°ø ÀÚ·á PDF. °ø°³ Çã¶ô ¹ÞÀ½

2. ȸ»ç ·ÐĪ ½ÉÆ÷Áö¾ö È«º¸ ÀÚ·á

3. ´ÚÅͺô web-seminar on fexuprazan (log-in é©)

4. À§¿°¿¡ ´ëÇÑ È¿°ú¸¦ UEGW¿¡ Æ÷½ºÅÍ·Î ¹ßÇ¥ÇÏ¿´´Ù´Â ½Å¹® ±â»ç

5. FEXUCLUE INSIGHT 5¿ùÈ£

6. Fexuclue - Beyond GERD 2024-09-25 ÀÌÁ¾¿µ ±³¼ö(¼º±Õ°üÀÇ´ë), Á¤À±¼÷ ±³¼ö(¼º±Õ°üÀÇ´ë) . Dr Ville (log-in é©)

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.